3//SEC Filing
OEP VII GP, L.L.C. 3
Accession 0000899243-20-018841
CIK 0001725255other
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 6:02 PM ET
Size
19.3 KB
Accession
0000899243-20-018841
Insider Transaction Report
Form 3
OEP VII GP, L.L.C.
10% Owner
Holdings
- 10,930,471(indirect: See footnotes)
Class A Common Stock
- (indirect: See footnotes)
Series A Convertible Preferred Stock
Exercise: $13.75→ Class A Common Stock (2,887,709 underlying)
Footnotes (3)
- [F1]These securities are held directly by OEP AHCO Investment Holdings, LLC ("Investor"). Investor is owned by One Equity Partners VII, L.P., a Cayman Islands exempted limited partnership ("OEP VII LP"), One Equity Partners VII-A, L.P., a Cayman Islands exempted limited partnership ("OEP VII-A LP"), and One Equity Partners VII-B, L.P., a Delaware limited partnership ("OEP VII-B LP" and, together with OEP VII-A LP and OEP VII LP, the "Parallel Funds"). The general partner of each of the Parallel Funds is OEP VII General Partner, L.P., a Cayman Islands exempted limited partnership ("OEP VII GP"), and the general partner of OEP VII GP is OEP VII GP, L.L.C., a Cayman Islands limited liability company ("OEP VII GP LLC"). OEP VII GP LLC is member-managed by Messrs. Richard Cashin and David Han.
- [F2](Continued from Footnote 1) By virtue of the relationships described above, each of the Parallel Funds, OEP VII GP, OEP VII GP LLC and Messrs. Richard Cashin and David Han may be deemed to beneficially own, and share voting and dispositive power with respect to, the securities held directly by Investor. Each of the reporting persons disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein.
- [F3]The number of shares of Class A Common Stock of AdaptHealth Corp., a Delaware corporation (the "Issuer"), having par value of $0.0001 per share (the "Class A Common Stock"), deliverable upon conversion of each share of Series A Convertible Preferred Stock, par value $0.0001 per share (the "Series A Preferred Stock"), is equal to 72.727273 shares, subject to customary anti-dilution and other adjustments. The terms of the Series A Preferred Stock generally restrict the conversion of such shares until the shares of Class A Common Stock issuable upon conversion thereof has been approved by stockholders of the Issuer in accordance with Nasdaq Listing Rules. Thereafter, the holder or the Issuer may convert the Series A Preferred Stock. The Series A Preferred Stock has no expiration date.
Documents
Issuer
AdaptHealth Corp.
CIK 0001725255
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001817118
Filing Metadata
- Form type
- 3
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 6:02 PM ET
- Size
- 19.3 KB